MMP3 and Parkinson disease: In addition, compared to those in PD patients with early-stage disease, MMP3 levels in advanced-stage PD patients were higher, while there were no significant differences between MMP3[12.56 (9.30, 17.44) vs. 15,31 (8.96, 25.49) ng/ml; P = 0.220].